Tag Archive for: neurological

Drug Discovery

Ipsen puts US$1.8bn in pipeline expansion in movement disorders

Ipsen SA and RNA splicing modifier specialist Skyhawk Therapeutics Inc have entered a US$1.8bn licencing option deal in rare neurological disorders.

Read more